RxDoctor Payments Data

Kelly Calleros, CNM

Advanced Practice Midwife · Livingston, NJNPI 1750790218

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,118 of the $1,463 with a category attached, or 76.4%. It is spread thinly across 18 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Among advanced practice midwife clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,463in general payments, 2019–2025

Across 78 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Celularity Inc.$300
  • Mayne Pharma Commercial LLC$221
  • Astellas Pharma US Inc$196
  • AbbVie$146
  • Millicent US Inc$120
  • Avion Pharmaceuticals$85
  • plus $396 from 12 others

What the payments were for

  • Speaking & faculty fees$30021%
  • Food & beverage$1,11876%
  • Education$453%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,463 in reported general payments places this provider in the 95th percentile of 199 advanced practice midwife providers in New Jersey.

See all advanced practice midwife providers in New Jersey

Medicare billing

Part B allowed, 2024
$5,281
Medicare patients
47
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated32$12,571
Estradiol41$3,722
ValacyclovirValacyclovir Hcl18$528

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$15$12,57132 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 199 advanced practice midwife providers in New Jersey.

Other advanced practice midwife in Livingston

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →